Natural Product: NPC177839

Natural Product IDNPC177839
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Pentaacetylquercetin
IUPAC Name [2-acetyloxy-4-(3,5,7-triacetyloxy-4-oxochromen-2-yl)phenyl] acetate
Synonyms NSC-115919
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL19074
PubChem CID 14005
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey JQUHMSXLZZWRHU-UHFFFAOYSA-N
Standard InCHI InChI=1S/C25H20O12/c1-11(26)32-17-9-20(35-14(4)29)22-21(10-17)37-24(25(23(22)31)36-15(5)30)16-6-7-18(33-12(2)27)19(8-16)34-13(3)28/h6-10H,1-5H3
SMILES CC(=O)Oc1cc(c2c(c1)oc(c1ccc(c(c1)OC(=O)C)OC(=O)C)c(c2=O)OC(=O)C)OC(=O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   512.1 Volume:   486.495
?
Van der Waals volume.
Dense:   1.053 LogP:   1.725
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.06
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.157
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   23.0
TPSA:   161.71
?
Topological Polar Surface Area.
H-Bond Acceptor:   12.0
H-Bond Donor:   0.0 Rings:   3.0
Heavy Atoms:   12.0

MedChem Properties

QED Drug-Likeness Score:   0.351 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.827 Fsp3:   0.2
MCE-18:   24.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.018 Fluc inhibitor:   0.422
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.996
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.725
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.356 Promiscuous compounds:   0.342

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.924 MDCK Permeability:   -4.516
Pgp-inhibitor:   0.998 Pgp-substrate:   0.02
PAMPA:   0.154
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.005
20% Bioavailability (F20%):   0.083 30% Bioavailability (F30%):   0.915
50% Bioavailability (F50%):   0.987

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.014 MRP1:   0.905
Plasma Protein Binding (PPB):   75.243% Volume Distribution (VD):   -0.379
Fu: 23.312%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.001
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.005 CYP1A2-substrate:   0.983
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.174
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.001
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.972
HLM stability:   0.994
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.335 Half-life (T1/2):  0.383

ADMET: Toxicity

hERG Blockers:  0.001 hERG Blockers (10um):  0.035
Human Hepatotoxicity (H-HT):  0.26 Drug-induced Liver Injury (DILI):  0.996
AMES Toxicity:  0.458 Rat Oral Acute Toxicity:  0.785
Maximum Recommended Daily Dose:  0.131 Skin Sensitization:  0.976
Carcinogencity:  0.06 Eye Corrosion:  0.773
Eye Irritation:  0.881 Respiratory Toxicity:  0.065
Drug-induced Neurotoxicity:  0.069 Ototoxicity:  0.027
Hematotoxicity:  0.671 Drug-induced Nephrotoxicity:  0.004
Genotoxicity:  0.942 RPMI-8226 Immunitoxicity:  0.012
A549 Cytotoxicity:  0.924 Hek293 Cytotoxicity:  0.095
BCF:   0.706
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.633
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.908
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.491
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28094 Consolida oliveriana Species Ranunculaceae Eukaryota n.a. n.a. n.a. PMID[19489596]
NPO33509 byrsonima coccolobifolia Species Malpighiaceae Eukaryota leaves and stems cerrado at the Federal University of So Carlos (UFSCar), So Carlos, SP, Brazil 2011-Jul PMID[24521209]
NPO33118 Rhamnus Genus Rhamnaceae Eukaryota n.a. n.a. n.a. PMID[8350094]
NPO28094 Consolida oliveriana Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO28094 Consolida oliveriana Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1558 Individual protein Aflatoxin B1 aldehyde reductase Rattus norvegicus Inhibition = 6.7 % PMID[27338658]
NPT1558 Individual protein Aflatoxin B1 aldehyde reductase Rattus norvegicus Inhibition = 12.8 % PMID[27338658]
NPT1558 Individual protein Aflatoxin B1 aldehyde reductase Rattus norvegicus Inhibition = 18.0 % PMID[27338658]
NPT1563 Individual protein Phosphodiesterase 2A Rattus norvegicus IC50 = 275000.0 nM Open TG-GATES in vivo data: Biochemistry
NPT1310 Individual protein Xanthine dehydrogenase Bos taurus Inhibition = 0.0 % PMID[23013356]
NPT1662 Individual protein Arginase Leishmania amazonensis IC50 = 120800.0 nM PMID[22608855]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1597 Cell line J774.2 n.a. IC50 = 109230.0 nM DOI[10.1016/j.cropro.2011.12.007]
NPT1597 Cell line J774.2 n.a. Ratio IC50 = 10.0 n.a. PubChem BioAssay data set
NPT1596 Organism Leishmania peruviana Leishmania peruviana IC50 = 11180.0 nM PMID[19691312]
NPT1208 Organism Leishmania braziliensis Leishmania braziliensis IC50 = 46780.0 nM PMID[16562830]
NPT1596 Organism Leishmania peruviana Leishmania peruviana Activity = 40.0 % PMID[22194678]
NPT1596 Organism Leishmania peruviana Leishmania peruviana Activity = 72.0 % PMID[22194678]
NPT1596 Organism Leishmania peruviana Leishmania peruviana Inhibition = 30.0 % PMID[19124664]
NPT20967 Cell line Platelet n.a. Activity = 2.4 % PMID[8350094]
NPT20967 Cell line Platelet n.a. Activity = 17.4 % PMID[8350094]
NPT20967 Cell line Platelet n.a. Activity = 89.2 % PMID[8350094]
NPT2 Others Unspecified n.a. IC50 = 355000.0 nM Open TG-GATES in vivo data: Biochemistry
NPT2 Others Unspecified n.a. IC50 = 126000.0 nM Open TG-GATES in vivo data: Biochemistry
NPT2 Others Unspecified n.a. Ratio = 0.46 n.a. Open TG-GATES in vivo data: Biochemistry
NPT2 Others Unspecified n.a. IC50 = 6800.0 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Inhibition = 90.0 % PMID[10691710]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus Activation = 7.1 % PMID[12182864]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activation = 13.3 % PMID[12182864]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activation = 25.0 % PMID[12182864]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activation = 37.0 % PMID[12182864]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 2.25 n.a. PMID[21546250]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 4.75 n.a. PMID[21546250]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC177839 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9245 High Similarity NPC472535
0.9057 High Similarity NPC474170
0.8704 High Similarity NPC474388
0.7925 Intermediate Similarity NPC474037
0.7321 Intermediate Similarity NPC605569
0.6667 Remote Similarity NPC310259
0.6533 Remote Similarity NPC475214
0.6129 Remote Similarity NPC34725
0.6129 Remote Similarity NPC608137
0.6125 Remote Similarity NPC476180
0.569 Remote Similarity NPC72452
0.5593 Remote Similarity NPC602291
0.5373 Remote Similarity NPC122623
0.5349 Remote Similarity NPC475434
0.5256 Remote Similarity NPC117478
0.5217 Remote Similarity NPC241774
0.519 Remote Similarity NPC481404
0.5167 Remote Similarity NPC61546
0.5161 Remote Similarity NPC259058
0.5079 Remote Similarity NPC90582
0.5079 Remote Similarity NPC299923
0.5077 Remote Similarity NPC153758
0.5077 Remote Similarity NPC605582

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC177839 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data